生化标本临床检验异常的原因分析及检验前的质量控制  

Analysis of the Causes of Clinical Test Abnormalities in Biochemical Specimens and Quality Control before Testing

作　　者：林浩潮 叶艳君 苏广游 周婉婷 Lin Hao-chao;Ye Yan-jun;Su Guang-you;Zhou Wan-ting(Dongguan Lanwei Medical Laboratory Co.,Ltd,Dongguan 523000,Guangdong Province,China)

机构地区：[1]东莞兰卫医学检验实验室有限公司,广东东莞523000

出　　处：《中国社区医师》2022年第35期87-89,共3页Chinese Community Doctors

摘　　要：目的:探讨生化标本临床检验时出现异常情况的原因以及检验之前质量控制存在的问题。方法:选择东莞兰卫医学检验实验室有限公司2020年2月-2021年6月检验的800份生化标本为研究对象,分析临床检验异常的原因和检验前质量控制的数据。结果:800份生化标本进行检验,其中生化标本检验出现异常有35份,占比为4.38%,而在检验前质量管理中存在的异常问题包括标本量少、标本溶血、餐后抽血、运动后抽血,占比分别为22.86%、17.14%、11.43%、8.57%。结论:在生化标本检验之前加强质量控制,可实现检验精准性的提升,避免出现检验异常,确保生化检验质量与检验效率。Objective:To explore the causes of clinical test abnormalities in biochemical specimens and the problems of quality control before testing.Methods:800 biochemical specimens tested in our hospital from February 2020 to June 2021 were selected for the study,and the causes of clinical test abnormalities and the data of pre-test quality control were analyzed.Results:800biochemical specimens were tested,among which 35 biochemical specimens were tested with abnormalities,accounting for4.38%.And the abnormal problems in pre-test quality control included low specimen volume,specimen hemolysis,postprandial blood sampling,and post-exercise blood sampling,accounting for 22.86%,17.14%,11.43%,and 8.57%,respectively.Conclusion:Strengthening quality control before testing biochemical specimens can achieve improvement of test accuracy,avoid test abnormalities,and ensure the quality and efficiency of biochemical tests.

关 键 词：生化标本 临床检验 质量控制 

分 类 号：R446.1[医药卫生—诊断学]